Loading ticker
Fetching market data and analysis
EGRXEagle Pharmaceuticals, Inc.
$0.25
0
(0%)
Healthcare > Drug Manufacturers - Specialty & Generic
AI OVERVIEW
Sign up to unlock the AI market state overview.
INVESTOR SUMMARY
1 of 6 unlocked
Overall Market Environment:
No analysis available.
Fundamental Expectations:
Detailed AI commentary for this dimension is available with a subscription.
Structural Position:
Detailed AI commentary for this dimension is available with a subscription.
Market Perception:
Detailed AI commentary for this dimension is available with a subscription.
Risk Environment:
Detailed AI commentary for this dimension is available with a subscription.
Stability & Signal Reliability:
Detailed AI commentary for this dimension is available with a subscription.
STATE ALIGNMENT
1 of 3 unlocked
Market bias
bearishneutralbullish
—
MARKET REGIME
Trend
—vs SMA200
No dataPhase: N/A
Insufficient data to assess trend.
Relative performance
••vs S&P 500 (3M)
Status: ••Benchmark: ••
Sign up to reveal
MOVE QUALITY
Momentum
RSI (14):••
RSI Change (5D):••
Liquidity
Rel Vol:••
Avg Vol (30D):••
RISK ENVIRONMENT
Volatility
ATR (14):••
ATR Percentile:••
Price damage
Drawdown vs 52W High:••
FUNDAMENTALS & MARKET PERCEPTION
Earning outlook
EPS Revision (3M):••
Guidance:••
Analyst confidence
Target trend (3M):••
Coverage:••
Financial Health
Cash runway:••
Net debt:••
Narrative momentum
Dominant theme:••